Kim Min, Sgagias Magda, Deng Xiyun, Jung Yun-Jin, Rikiyama Toshiki, Lee Kwangmoon, Ouellette Michel, Cowan Kenneth
Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68198-6805, USA.
Biochem Biophys Res Commun. 2004 Jul 16;320(1):138-44. doi: 10.1016/j.bbrc.2004.05.135.
The INK4A/ARF locus on chromosome 9 is a tumor suppressor gene frequently mutated in human cancers. In order to study the effects of p14ARF expression in tumor cells, we constructed a recombinant adenovirus containing p14ARF cDNA (Adp14ARF). Adp14ARF infection of U2OS osteosarcoma cells which has wild type p53 and mutant p14ARF revealed high levels of p14 (ARF) expression within 24h. In addition, Adp14ARF-mediated expressing of p14 (ARF) was associated with increased levels of p53, p21, and mdm2 protein. Growth inhibition assays following Adp14ARF infection demonstrated that the growth of U2OS cells was inhibited relative to infection with control virus. Furthermore, TUNEL analysis as well as PARP cleavage assays demonstrated that Adp14ARF infection was associated with increased apoptosis in U2OS cell line and that it was associated with Adp14ARF induced overexpression of Fas and Fas-L. Addition of Fas-L neutralizing antibody NOK-1 decreased Adp14-mediated cell death, indicating that p14 (ARF) induction of the Fas pathway is associated with increased apoptosis. The finding that Adp14ARF infection did not induce Fas expression in U2OS/E6 and MCF/E6 cells suggests that wild type p53 expression may be necessary for Adp14ARF-mediated induction of Fas. The observation that overexpression of p53 by Adp53 infection in MCF-7 does not induce increased Fas protein levels nor apoptotic cell death suggests that p53 overexpression is required but not sufficient enough for apoptosis. These studies suggest there are other mechanisms other than induction of p53 in ARF-mediated apoptosis and gene therapy using Adp14ARF may be a promising treatment option for human cancers containing wild type p53 and mutant or deleted p14 expression.
位于9号染色体上的INK4A/ARF基因座是一种肿瘤抑制基因,在人类癌症中经常发生突变。为了研究p14ARF在肿瘤细胞中的表达作用,我们构建了一个含有p14ARF cDNA的重组腺病毒(Adp14ARF)。用Adp14ARF感染具有野生型p53和突变型p14ARF的U2OS骨肉瘤细胞后,在24小时内显示出高水平的p14(ARF)表达。此外,Adp14ARF介导的p14(ARF)表达与p53、p21和mdm2蛋白水平的增加有关。Adp14ARF感染后的生长抑制试验表明,与对照病毒感染相比,U2OS细胞的生长受到抑制。此外,TUNEL分析以及PARP切割试验表明,Adp14ARF感染与U2OS细胞系中凋亡增加有关,并且与Adp14ARF诱导的Fas和Fas-L过表达有关。添加Fas-L中和抗体NOK-1可减少Adp14介导的细胞死亡,表明p14(ARF)诱导Fas途径与凋亡增加有关。Adp14ARF感染在U2OS/E6和MCF/E6细胞中未诱导Fas表达这一发现表明,野生型p53表达可能是Adp14ARF介导的Fas诱导所必需的。在MCF-7中通过Adp53感染使p53过表达但未诱导Fas蛋白水平增加和凋亡细胞死亡这一观察结果表明,p53过表达是凋亡所必需的,但并不足以诱导凋亡。这些研究表明,在ARF介导的凋亡中,除了诱导p53外还有其他机制,并且使用Adp14ARF进行基因治疗可能是含有野生型p53以及突变或缺失p14表达的人类癌症的一种有前景的治疗选择。